###begin article-title 0
Impact of Glutathione S-Transferase M1 and T1 Gene Polymorphisms on the Smoking-Related Coronary Artery Disease
###end article-title 0
###begin p 1
###xml 142 150 142 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1/T1</italic>
###xml 413 418 413 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 423 428 423 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 533 539 533 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1A1</italic>
###xml 730 735 730 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 740 745 740 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 822 827 822 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 888 893 888 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 961 966 961 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 1067 1072 1067 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 1142 1147 1142 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 1195 1203 1195 1203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1/T1</italic>
###xml 1360 1368 1360 1368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1/T1</italic>
###xml 250 258 <span type="species:ncbi:9606">patients</span>
###xml 588 596 <span type="species:ncbi:9606">patients</span>
Glutathione S-transferase (GST) plays a key role in the detoxification of xenobiotic atherogen generated by smoking. To analyze the effect of GSTM1/T1 gene polymorphisms on the development of smoking-related coronary artery disease (CAD), 775 Korean patients who underwent coronary angiography were enrolled. The subjects were classified by luminal diameter stenosis into group A (>50%), B (20-50%), or C (<20%). GSTM1 and GSTT1 gene polymorphisms were analyzed using multiplex polymerase chain reaction (PCR) for GSTM1/T1 genes and CYP1A1 gene for internal control. Of 775 subjects, 403 patients belonged to group A. They had higher risk factors for CAD than group B (N=260) and group C (N=112). The genotype frequencies of null GSTM1 and GSTT1 showed no significant differences among 3 groups. Considering the effect of GSTM1 gene polymorphisms on the smoking-related CAD, smokers with GSTM1 null genotype had more increased risk for CAD than non-smoker with GSTM1 positive genotype (odds ratios [OR], 2.07, confidence interval [CI], 1.06-4.07). Also the effect of GSTT1 gene polymorphism on smoking-related CAD showed the same tendency as GSTM1 gene (OR, 2.00, CI, 1.05-3.84). This effect of GSTM1/T1 null genotype on smoking-related CAD was augmented when both gene polymorphisms were considered simultaneously (OR, 2.76, CI, 1.17-6.52). We concluded that GSTM1/T1 null genotype contributed to the pathogenesis of smoking-related CAD to some degree.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 538 539 538 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
Atherosclerosis and coronary artery disease (CAD), which is developed as a complication of atherosclerosis, are one of the major causes of death in the world (1). Traditional risk factors of coronary artery disease are hypertension, diabetes mellitus, dyslipidemia, and smoking. However, these factors can only explain approximately two thirds of the observed clinical events. This has maintained interest in other nutritional, biochemical, and genetic factors that might contribute to the underlying pathophysiology of vascular disease (2).
###end p 3
###begin p 4
###xml 143 144 143 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 613 614 613 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 616 617 616 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 743 744 743 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
Cancers as well as CAD are also the main causes of death in developed countries. They share common disease origin and pathogenetic mechanisms (3). Recent studies addressing the issue of somatically acquired DNA mutations in the pathogenesis of atherosclerosis suggest that the occurrence of DNA alterations contribute to the multifaceted pathogenesis of the atherogenic process. In particular, deletions or mutations of gene coding for enzymes involved in the metabolism of hazardous compounds may be responsible for individual susceptibility to genotoxic factors, predisposing to the development of DNA insults (4, 5). Also twin and nuclear family studies provide compelling evidence of a genetic component underlying cardiovascular disease (6).
###end p 4
###begin p 5
###xml 273 274 273 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 411 412 398 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 501 506 480 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 597 602 576 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 640 645 619 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 674 679 653 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 707 713 686 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1a</italic>
###xml 717 723 696 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1b</italic>
###xml 751 752 730 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 755 760 734 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 917 919 896 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 921 923 900 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 115 122 <span type="species:ncbi:4097">tobacco</span>
###xml 321 327 <span type="species:ncbi:9606">humans</span>
The glutathione S-transferases (GST) are a family of enzymes that detoxify reactive electrophiles, particularly in tobacco smoke, products of oxidative stress, and known or suspected carcinogenic compounds such as benzo[a]pyrene and other polycyclic aromatic hydrocarbons (7). There are four classes of GST isoenzymes in humans (micro, pi, theta, and alpha), with partially overlapping substrate specificities (8). GST M1 enzyme belongs to the micro class and the GSTT1 enzyme to the theta class. The GSTM1 gene on chromosome 1p13, according to the three alleles, can be grouped into two classes: GSTM1-null homozygote for the null allele (GSTM1-0), nonfunctional class and GSTM1-1 with at least one of the GSTM1a or GSTM1b alleles, functional class (9). GSTM1-null was reported to be associated in some studies with increased susceptibility to inflammatory pathologies and increased risk of smoking-related cancers (10, 11).
###end p 5
###begin p 6
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 71 76 71 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 114 119 114 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 128 133 128 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 201 206 201 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
Similarly, GSTT1 gene on chromosome 22q11,2 has two classes denoted as GSTT1-null homozygote for the null allele (GSTT1-0), and GSTT1-1 with at least one functional allele. The GSTT1 enzyme encoded by GSTT1-1 catalyzes the detoxification of monohalomethanes and ethylene oxide, present in cigarette smoke (12), and deficiency of its activity is associated with high risk of smoking-related cancers (13).
###end p 6
###begin p 7
###xml 457 459 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 612 614 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 648 650 648 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 697 699 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 746 751 746 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 756 761 756 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 918 921 918 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GST</italic>
###xml 955 956 955 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 958 960 958 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 0 7 <span type="species:ncbi:4097">Tobacco</span>
Tobacco smoke is a major cause of both cancer and cardiovascular diseases. Although its carcinogenic role via induction of DNA damage and mutation is well established, the mechanisms involved in vascular disease remain unclear. One possible cause is that DNA damage causes smooth muscle cell proliferation in the intima of arteries, thereby contributing to atherothrombotic processes. The binding of chemicals to DNA is modulated by detoxification enzymes (14). Mutagenic and mitogenic activity of cigarette smoke chemicals can cause DNA adducts in target tissues and the oxidative modification of lipoproteins (15), endothelial cell regeneration (16), and progression of atherosclerotic lesions (15). Epidemiological studies have indicated that GSTM1 and GSTT1 polymorphisms are associated with increased risk for different cancers among smokers, but there are still some controversies about the relationship between GST polymorphism and CAD in smokers (7, 17).
###end p 7
###begin p 8
###xml 293 298 293 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 303 308 303 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 474 479 474 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 484 489 484 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 77 84 <span type="species:ncbi:4097">tobacco</span>
The GST enzyme is implicated in the detoxification of carcinogens present in tobacco smoke and consequently polymorphisms in this gene may confer susceptibility to cardiovascular disease if DNA damage is important in the development of CAD. So the aims of this study are to assess whether the GSTM1 and GSTT1 genotypes are associated with CAD, and to ascertain whether the risk of CAD given exposure to cigarette smoking is modified by the specific genetic polymorphisms of GSTM1 and GSTT1.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
Subjects
###end title 10
###begin p 11
###xml 1728 1729 1728 1729 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 38 46 <span type="species:ncbi:9606">patients</span>
###xml 989 997 <span type="species:ncbi:9606">patients</span>
###xml 1073 1081 <span type="species:ncbi:9606">patients</span>
###xml 1210 1218 <span type="species:ncbi:9606">patients</span>
###xml 1314 1322 <span type="species:ncbi:9606">patients</span>
###xml 1475 1483 <span type="species:ncbi:9606">patients</span>
###xml 1551 1559 <span type="species:ncbi:9606">patients</span>
The study population consisted of 775 patients who had undergone coronary angiography from June 2004 to March 2005 in Kyunghee University Hospital. Most of them (703 of 775) had received the coronary angiography for confirmative diagnosis and treatment of ischemic heart disease with typical chest pain, and 72 subjects for preoperative evaluation of valvular heart disease or other reasons. We classified the subjects into 3 groups according to the degree of luminal diameter stenosis in coronary angiography: group A represents subjects with more than 50% of luminal diameter stenosis, group B with luminal diameter stenosis between 20% and 50%, and group C with less than 20%. Smoking history, hypertension, diabetes mellitus, family history of cardiovascular disease, and obesity were evaluated by history taking and physical examination. Smoker was defined as both current smoker and ex-smoker who had previously been exposed to smoking for at least 5 yr. Hypertension was defined as patients who had been previously diagnosed and received anti-hypertensive drugs, or patients whose blood pressure level was more than 140 mmHg in systole or more than 90 mmHg in diastole. Diabetes mellitus was defined as patients who had been previously diagnosed and received oral hypoglycemic agents or insulin therapy, or patients whose fasting blood glucose (FBS) was above 126 mg/dL or postprandial 2 hour blood glucose (PP2hr glucose) above 200 mg/dL. Dyslipidemia was defined as patients who had taken statin treatment with diagnosis of hyperlipidemia or patients whose low-density lipoprotein cholesterol (LDL) level was above 160 mg/dL or high-density lipoprotein cholesterol (HDL) level below 40 mg/dL. Body mass index (BMI, kg/m2) was calculated using the height and weight. Informed consent was obtained from all subjects, and the study was approved by the Ethical Committee of Kyunghee University.
###end p 11
###begin title 12
Methods
###end title 12
###begin title 13
Blood test
###end title 13
###begin p 14
We determined the baseline blood test including the FBS, PP2hr glucose and lipid profile such as total cholesterol, triglyceride, LDL and HDL.
###end p 14
###begin title 15
Coronary angiography
###end title 15
###begin p 16
Coronary angiography was carried out according to the Judkins techinique, and images of the right and left coronary trees were obtained in routine standardized projections with Philips Integris Allura 9 system (Philips Medical, Eindhoven, Netherlands). Quantitative coronary angiography was executed by experienced angiographers who were blind to the results of genotype analysis. CAD was defined as luminal diameter narrowing more than 50% in at least one epicardial coronary artery. The severity of CAD was determined by the number of affected vessels in coronary arteris (one-, two-, or three-vessel disease). Also we devided the CAD according to the degree of luminal narrowing into mild (50-75%), moderate (75-90%), and severe (more than 90%).
###end p 16
###begin title 17
Genetic assessment
###end title 17
###begin p 18
###xml 0 31 0 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Blood samples and DNA isolation</italic>
Blood samples and DNA isolation Venous blood of 3 mL was obtained from all subjects and collected in sterile tubes containing ethylenediaminetetraacetic acid (EDTA). Immediately after collection, whole blood was stored at -20℃ until use. Genomic DNA was extracted from whole blood by using Whole Blood Genomic DNA Purification (Rapid Spin Type, CoreBio, Indianapolis, IN, U.S.A.)
###end p 18
###begin p 19
###xml 0 46 0 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Analysis of GSTM1 and GSTT1 gene polymorphisms</italic>
###xml 89 94 89 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 99 104 99 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 218 220 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 255 258 255 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GST</italic>
###xml 268 273 268 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 278 283 278 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 348 354 348 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1A1</italic>
###xml 458 463 458 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 554 559 554 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 653 659 653 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1A1</italic>
###xml 325 330 <span type="species:ncbi:9606">human</span>
Analysis of GSTM1 and GSTT1 gene polymorphisms The genetic polymorphism analyses for the GSTM1 and GSTT1 gene were determined by the multiplex polymerase chain reaction (PCR) modifying the previously described method (18). The appropriate fragment of the GST gene for GSTM1 and GSTT1 was amplified with specific primers from human genomic DNA. The CYP1A1 gene was coamplified as an internal positive control. The following primers were used in PCR reaction: GSTM1 primers of (sense) 5-GAACTCCCTGAAAAGCTAAAGC-3 and (antisense) 5-GTTGGGCTCAAATATACGGTGG-3, GSTT1 primers of (sense) 5-TTCCTTACTGGTCCTCACATCTC-3 and (antisense) 5-TCACGGGATCATGGCCAGCA-3, and CYP1A1 (sense) 5-GAACTGCCACTTCAGCTGTCT-3 and (antisense) 5-CAGCTGCATTTGGAAGTGCTC-3.
###end p 19
###begin p 20
###xml 567 572 557 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 581 586 571 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 595 601 585 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1A1</italic>
PCR was performed in a total volume of 30 microL reaction mix containing 100 microg genomic DNA, 5rhoM of each primer, 2.5 mM deoxyribonucleoside triphosphates, 1.5 mM MgCl2, 100 mM Tris-HCL, and 1 U thermostable Taq DNA polymerase with GeneAmp PCR system 2700 (Applied Biosystems, Foster, CA, U.S.A.). The amplification conditions were initial denaturation at 94℃ for 5 min followed by 35 cycles of denaturation at 94℃ for 45 sec, annealing at 59℃ for 50 sec, extension at 72℃ for 1 min, and final extension at 72℃ for 10 min. The products of the PCR amplification (GSTM1:215 bp, GSTT1:480 bp, CYP1A1:312 bp) were separated then electrophoretically on an ethidium bromide-stained 2% agarose gel.
###end p 20
###begin title 21
Statistical analysis
###end title 21
###begin p 22
###xml 402 403 398 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 526 531 522 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 536 541 532 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 765 766 761 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Statistical analysis of data was conducted with SPSS 12.0 program. Data of continuous variables were expressed as mean +/-standard deviation and data of noncontinuous variables as frequency (N, %). Differences of means among group A, B, and C were evaluated by one-way analysis of variance (ANOVA). Comparison of noncontinuous variables and genotype distribution among 3 groups were tested by using chi2 test (2 x 2 continency table). We calculated odds ratios (OR) and 95% confidence interval (CI) for the association of the GSTM1 and GSTT1 genotypes with the development of CAD using unconditional logistic regression. The OR was also adjusted for other coronary risk factors. Independent factors on CAD risk were evaluated by multiple logistic regression model. p values of <0.05 were considered statistically significant.
###end p 22
###begin title 23
RESULTS
###end title 23
###begin title 24
Clinical characteristics
###end title 24
###begin p 25
###xml 59 66 59 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 549 550 543 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 787 788 781 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The clinical characteristics for 775 subjects are shown in Table 1. Of 775 subjects, 403 subjects belonged to group A, 260 to group B, and 112 to group C. The prevalence of known atherogenic risk factors, such as smoking habits, hypertension, diabetes, dyslipidemia, obesity, and sex (male) were significantly higher in group A as compared with group B and C. We found that the HDL level was significantly lower in group A than in group B and C (36.0+/-12.0 in group A vs. 40.5+/-11.3 in group B, and vs. 40.2+/-10.5 mg/dL in group C, respectively, p<0.05). Average smoking history was 30.2 pack years. There was no difference in smoking habits between group A and B, but there was significant difference between group A and C (31.4 pack years in group A vs. 26.8 pack years in group C, p<0.05). There was no significant difference in clinical characteristics between group B and C.
###end p 25
###begin title 26
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1/T1</italic>
GSTM1/T1 gene polymorphism
###end title 26
###begin p 27
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 109 114 109 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 158 164 158 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1A1</italic>
###xml 289 295 289 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
The internal standard fragment amplified from GSTM1 gene was 215 bp. A 480-bp fragment was amplified for the GSTT1 gene, and 312-bp fragment was obtained for CYP1A1 gene. The absence of other amplified products with only presence of 312-bp fragment was consistent with the null genotypes (Fig. 1).
###end p 27
###begin p 28
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
We acquired data for GSTM1 gene and GSTT1 gene polymorphisms in 692 subjects (89.3%) due to missing data of gene analysis (missing data [83]: group A [47], B [34], and C [2]).
###end p 28
###begin title 29
###xml 16 24 16 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1/T1</italic>
The relation of GSTM1/T1 gene polymorphism to coronary artery disease
###end title 29
###begin p 30
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 93 100 93 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 255 258 255 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GST</italic>
###xml 337 342 337 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 432 437 432 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 472 473 472 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 503 508 503 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 678 683 678 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 758 763 758 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 827 834 827 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
There was no significant difference in GSTM1 and GSTT1 genotype distribution among 3 groups (Table 2). We found no difference in genotype distribution among 3 groups when we classified subjects into smokers and non-smokers. When the risks associated with GST genotypes for CAD were considered in relation to smoking habits, smokers with GSTM1 null genotype were at an approximately 2.07-fold higher risk of CAD than nonsmokers with GSTM1-positive genotype (CI, 1.06-4.07, p=0.03). However, smokers with GSTM1-positive genotype had no increased risk for CAD as compared with non-smokers (OR, 1.21, CI, 0.64-2.27). In non-smokers, there was no difference in CAD risk according to GSTM1 genotype (OR, 0.96, CI, 0.56-1.66). There was no effect of interaction of GSTM1 genotype and smoking on CAD development between group B and C (Table 3).
###end p 30
###begin p 31
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 106 111 106 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 131 136 131 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 225 230 225 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 265 266 265 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 296 301 296 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 473 478 473 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 553 558 553 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 621 628 621 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">Table 4</xref>
The effect of interaction of GSTT1 gene and smoking on CAD risk, we found the similar results as those in GSTM1 gene. Smokers with GSTT1 null genotype were at an approximately 2.0-fold higher risk of CAD than nonsmokers with GSTT1 positive genotype (CI, 1.05-3.84, p=0.03). However, smokers with GSTT1-positive genotype had no increased risk for CAD as compared with non-smokers (OR, 1.44, CI, 0.74-2.84). In non-smokers, there was no difference in CAD risk in relation to GSTT1 genotype (OR, 0.77, CI, 0.45-1.31). There was no effect of interaction of GSTT1 genotype and smoking on CAD development between group B and C(Table 4).
###end p 31
###begin p 32
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 147 152 147 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 157 162 157 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 257 262 257 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 267 272 267 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 307 308 307 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Considering the synergistic effects of GSTM1 null genotype and GSTT1 null genotype on risk of smoking-related CAD, we found that smokers with both GSTM1 and GSTT1 null genotype were at an approximately 2.76-fold higher risk of CAD than nonsmokers with both GSTM1 and GSTT1 positive genotype (CI, 1.17-6.52, p=0.04)
###end p 32
###begin p 33
###xml 140 151 140 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1/GSTT1</italic>
###xml 228 233 228 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 274 275 274 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 297 302 297 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 343 344 343 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 352 359 352 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">Table 5</xref>
###xml 361 362 361 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T6">6</xref>
After adjusting other coronary risk factors such as hypertension, diabetes, dyslipidemia, age, and sex than smoking, the interactive effect GSTM1/GSTT1 gene and smoking on CAD remained statistically significant (in smokers with GSTM1 null genotype, OR, 2.01, CI, 1.13-3.69, p=0.01/in smokers with GSTT1 null genotype, OR, 1.89, CI, 1.03-3.13, p=0.02) (Table 5, 6).
###end p 33
###begin p 34
###xml 31 42 31 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1/GSTT1</italic>
###xml 119 130 119 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1/GSTT1</italic>
###xml 218 225 218 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T7">Table 7</xref>
###xml 269 280 269 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1/GSTT1</italic>
###xml 314 321 314 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T8">Table 8</xref>
As we considered the effect of GSTM1/GSTT1 genotype on the multivessel disease, there was no significant difference in GSTM1/GSTT1 genotype in relation to the number of involved vessel in both smokers and non-smokers (Table 7). Also, there was no significant effect of GSTM1/GSTT1 genotype on the severity of CAD (Table 8).
###end p 34
###begin p 35
###xml 212 217 212 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 222 227 222 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 293 301 293 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1/T1</italic>
###xml 359 366 359 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T9">Table 9</xref>
We examined independent risk factors for CAD by multiple logistic regression analysis. Smoking, hypertension, diabetes, old age more than 50 yr, male, and dyslipidemia were independent risk factors for CAD. Both GSTM1 and GSTT1 null genotype in smokers were also independent risk factors, but GSTM1/T1 null genotype itself was not an independent risk factor (Table 9).
###end p 35
###begin title 36
DISCUSSION
###end title 36
###begin p 37
###xml 486 488 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 715 716 715 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 396 403 <span type="species:ncbi:9606">persons</span>
###xml 418 425 <span type="species:ncbi:4097">tobacco</span>
Cardiovascular diseases and cancer are the main causes of death in developed countries to which cigarette smoking is a major contributing factor. Cancer and atherosclerosis share common risk factors, such as cigarette smoking, physical inactivity, exposure to certain environmental mutagenic agents, and dietary habits. Autopsy studies have demonstrated higher risk for severe atherosclerosis in persons who died from tobacco-related cancers than those who died from extraneous causes (19). The facts that monoclonal proliferation of vascular smooth muscle cells in atherosclerosis is similar to process in carcinogenic progression (20) and that somatic mutation contributes to the developement of atherosclerosis (4) suggest that cardiovascular diseases and cancers share common pathogenic mechanisms.
###end p 37
###begin p 38
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 42 49 <span type="species:ncbi:4097">tobacco</span>
###xml 251 258 <span type="species:ncbi:4097">tobacco</span>
Epidemiological studies have demonstrated tobacco smoke is a major cause of both cancer and vascular diseases. However, the mechanism by which exposure leads to disease is better understood in the former case. There are many identified carcinogens in tobacco smoke that induce DNA damage by direct binding to form DNA adducts (21). Unrepaired DNA damage can result in the induction of somatic mutations in genes regulating cell growth, thus providing a mechanism for carcinogenesis.
###end p 38
###begin p 39
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 628 630 628 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 893 895 893 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 421 427 <span type="species:ncbi:9606">humans</span>
###xml 467 474 <span type="species:ncbi:4097">tobacco</span>
###xml 537 544 <span type="species:ncbi:4097">tobacco</span>
###xml 654 660 <span type="species:ncbi:9606">humans</span>
###xml 674 681 <span type="species:ncbi:4097">tobacco</span>
###xml 820 825 <span type="species:ncbi:9606">human</span>
By contrast, the mechanism by which smoking contributes the development of vascular diseases is not certain yet. One possible explanation is that smoking-induced DNA damage causes smooth muscle cell proliferation in the intima of arteries, thereby contributing to atherothrombotic processes (14). The hypothesis that DNA damage plays a role in vascular disease has received support from observations in animal models and humans. In experimental animals, chemicals in tobacco smoke (e.g., benzo(a)pyrene, 1,3-butadiene) and environmental tobacco smoke have been reported to induce and stimulate atherosclerotic plaque formation (11). In addition, in both humans and animals, tobacco carcinogens induce DNA adducts in cells of the vasculature at high levels, and aromatic DNA adducts are present in smooth muscle cells of human atherosclerotic lesion of the abdominal aorta and in heart tissue (22).
###end p 39
###begin p 40
###xml 176 177 176 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 771 773 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 775 777 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 779 781 775 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 808 816 804 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1/T1</italic>
###xml 935 936 931 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 938 940 934 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 942 944 938 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 89 96 <span type="species:ncbi:4097">tobacco</span>
###xml 326 333 <span type="species:ncbi:4097">tobacco</span>
###xml 461 468 <span type="species:ncbi:4097">tobacco</span>
GST is a family of enzymes that detoxify reactive electrophiles, particularly present in tobacco smoke, reactive oxygen species, and known or suspected carcinogenic compounds (7). Modulation of DNA damage and mutation caused by polymorphisms in detoxification enzymes, including the GST, is a well-established risk factor for tobacco-related carcinogenesis and a similar change in cellular damage may be involved in the risk of vascular disease associated with tobacco smoking (23). Also the binding of xenotoxic chemicals to DNA is modulated by detoxification enzymes such as GST. Of four classes of GST isoenzymes, null genotypes of GSTM1 which belongs to the micro class and of GSTT1 which is in the class are associated with increased risk of smoking-related cancer (10, 11, 13). However, association of GSTM1/T1 gene polymorphism with smoking-related CAD is revealed in few studies and the results of these studies are different (7, 17, 24).
###end p 40
###begin p 41
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 141 146 141 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 151 156 151 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 246 247 246 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 278 279 278 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 316 327 316 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1/GSTT1</italic>
###xml 369 374 369 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 379 384 379 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 435 436 435 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 466 477 466 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1/GSTT1</italic>
###xml 692 703 692 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1/GSTT1</italic>
###xml 874 885 874 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1/GSTT1</italic>
In this study, we tested whether specific genotypes of GSTM1 or GSTT1 may affect susceptibility to smoking-related CAD. The null genotype of GSTM1 and GSTT1 in smokers were associated with an increase in the risk of CAD (OR, 2.07, CI, 1.06-4.07, p=0.03; OR, 2.0, CI, 1.05-3.84, p=0.03), respectively. The effects of GSTM1/GSTT1 genotype on CAD were augmented when both GSTM1 and GSTT1 genotype were null type (OR, 2.76, CI, 1.17-6.52, p=0.04). However, smokers with GSTM1/GSTT1-positive genotype had no increased risk for CAD as compared with non-smokers (OR, 1.21, CI, 0.64-2.27; OR, 1.44, CI, 0.74-2.84, respectively). In non-smokers, there was no difference in risk for CAD in relation to GSTM1/GSTT1 genotype (OR, 0.96, CI, 0.56-1.66; OR, 0.77, CI, 0.45-1.31, respectively). These facts suggest that there may be different disease susceptibility to CAD according to the GSTM1/GSTT1 genotypes in smokers.
###end p 41
###begin p 42
###xml 86 89 86 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GST</italic>
###xml 173 178 173 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 239 240 239 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 390 395 390 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 435 440 435 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 460 462 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 499 504 499 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 555 557 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 747 752 747 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 833 835 833 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 733 741 <span type="species:ncbi:9606">patients</span>
As mentioned above, there are still some controversies about the relationship between GST polymorphism and CAD in smokers. An epidemiological study showed that smokers with GSTM1 null genotype have a consistently higher prevalence of CAD (7). De Waart and colleagues reported that the 2-yr progression of common carotid intima media thickness was clearly more increased in smokers with the GSTM1 null genotype than in smokers with the GSTM1-positive genotype (25). Recent data also suggest that the GSTM1 null genotype predisposes subjects to severe CAD (26). Our study showed similar results to those previously reported. By contrast, another study reported a significantly decreased risk for acute myocardial infarction in smoking patients with GSTM1 null genotype, but only in those having a previous history of the same disease (17).
###end p 42
###begin p 43
###xml 81 86 81 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 182 187 182 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 267 272 267 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 366 367 366 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 559 560 559 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 765 767 761 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 852 857 848 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 867 872 863 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 1034 1036 1030 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 1173 1178 1169 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 1194 1196 1190 1192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1477 1480 1473 1476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GST</italic>
Meanwhile, previous studies showed the more diverse results about the effects of GSTT1 gene polymorphism on smoking-related CAD. A recent study and our study found that smokers with GSTT1 null genotype had increased risk for CAD (24), but other studies revealed that GSTT1 positive genotype was associated with increased risk for CAD and peripheral artery diseases (7). A possible explanation for these conflicting results is that GSTT1 protein activates some chemicals present in cigarette smoke in more toxic forms and increase the risk of atherosclerosis (7). Indeed, although mammalian GST theta behaves as a scavenger towards electrophiles such as epoxides, it acts also as metabolic activator, producing intermediates potentially dangerous for DNA and cells (27). However, cytogenetic studies have shown that blood cultures from individuals with GSTT1 null and GSTM1 null genotypes have increased in vitro sensitivity to various genotoxins resulting in an increased level of chromosomal and oxidative DNA damage in lymphocytes (28). And levels of adducts to DNA in smooth muscle cells from atherosclerotic lesions are consistently increased in individuals having the GSTM1 null genotype (22). Consequently, genetic polymorphisms that affect xenobiotic metabolism or cellular response to DNA damage by modulating individual sensitivity to genotoxins may be important in modulating susceptibility to both cancer and atherosclerosis. In particular, the polymorphic genes of GST family of enzymes, which are involved in the detoxification of many compounds in cigarette smoke, may be relevant to the susceptibility to smoking-related diseases.
###end p 43
###begin p 44
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 369 370 369 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
The effect of cigarette smoking on atherosclerosis involves many metabolic and biological processes, such as endothelial injury, oxidation of low-density lipoprotein and changes in the hemostatic system (29). In addition, some of the adverse effects of smoking may result from DNA damage by genotoxic and carcinogenic agents including polycyclic aromatic hydrocarbons, n-nitrosamines, and reactive oxygen species in cigarette smoke.
###end p 44
###begin p 45
Our data may provide additional information to the understanding of smoking-related cardiovascular risk. Although there are several mechanisms of smoking-related CAD, it is thought to be important that deleted polymorphisms in the GST genes may influence the susceptibility to smoking-induced CAD by modulating the detoxification of genotoxic atherogens.
###end p 45
###begin article-title 46
Cardiovascular disease: a historical perspective
###end article-title 46
###begin article-title 47
Genetic architecture of common multifactorial diseases
###end article-title 47
###begin article-title 48
Atherosclerosis and cancer: common molecular pathways of disease development and progression
###end article-title 48
###begin article-title 49
Molecular epidemiology of atherosclerosis
###end article-title 49
###begin article-title 50
###xml 66 71 <span type="species:ncbi:9606">human</span>
Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques
###end article-title 50
###begin article-title 51
Genetic susceptibility to death from coronary heart disease in a study of twins
###end article-title 51
###begin article-title 52
Glutathione S-transferase genotype as a susceptibility factor in smoking-related coronary heart disease
###end article-title 52
###begin article-title 53
Enzymology of cytosolic glutathione S-transferases
###end article-title 53
###begin article-title 54
###xml 101 106 <span type="species:ncbi:9606">human</span>
The hereditary transmission of high glutathione transferase activity towards trans-stilbene oxide in human mononuclear leukocytes
###end article-title 54
###begin article-title 55
Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1(GSTM1) that increases susceptibility to bladder cancer
###end article-title 55
###begin article-title 56
###xml 57 64 <span type="species:ncbi:4097">tobacco</span>
1,3 Butadience, a vapor phase component of environmental tobacco smoke, accelerates arteriosclerotic plaque development
###end article-title 56
###begin article-title 57
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism
###end article-title 57
###begin article-title 58
Combined analysis of inherited polymorphisms in arylamine N-acetyltransferse 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk
###end article-title 58
###begin article-title 59
International Commission for Protection Against Environmental Mutagens and Carcinogens. The possible involvement of somatic mutations in the development of atherosclerotic plaques. Report of ICPEMC Subcommittee 7/1. Conclusions and recommendations
###end article-title 59
###begin article-title 60
###xml 160 167 <span type="species:ncbi:9986">rabbits</span>
Oxidants in cigarette smoke extract modify low-density lipoprotein in the plasma and facilitate atherogenesis in the aorta of Watanabe heritable hyperlipidemic rabbits
###end article-title 60
###begin article-title 61
Effect of cigarette smoke on endothelial regeneration in vivo and nitric oxide levels
###end article-title 61
###begin article-title 62
Glutathione S-transferase M1 null genotype is associated with a decreased risk of myocardial infarction
###end article-title 62
###begin article-title 63
Association of genetic polymorphism of glutathione S-transferase M1, T1, P1 and susceptibility to bladder cancer
###end article-title 63
###begin article-title 64
Atherosclerosis and malignant tumours
###end article-title 64
###begin article-title 65
###xml 16 21 <span type="species:ncbi:9606">human</span>
DNA adducts and human atherosclerotic lesions
###end article-title 65
###begin article-title 66
Increased DNA alterations in atherosclerotic lesions of individuals lacking the GSTM1 genotype
###end article-title 66
###begin article-title 67
Association between the risk of coronary artery disease in South Asians and a deletion polymorphism in glutathione S-transferase M1
###end article-title 67
###begin article-title 68
Interactive effect of the glutathione S-transferase genes and cigarette smoking on occurrence and severity of coronary artery risk
###end article-title 68
###begin article-title 69
Effect of glutathione S-transferase M1 genotype on progression of atherosclerosis in lifelong male smokers
###end article-title 69
###begin article-title 70
Glutathione S-transferase mu1 deficiency, cigarette smoking and coronary artery disease
###end article-title 70
###begin article-title 71
Mammalian class theta GST and differential susceptibility to carcinogens: a review
###end article-title 71
###begin article-title 72
###xml 114 120 <span type="species:ncbi:9606">humans</span>
Glutathione S-transferase polymorphisms influence the level of oxidative DNA damage and antioxidant protection in humans
###end article-title 72
###begin article-title 73
Smoking and cardiovascular disease
###end article-title 73
###begin p 74
###xml 37 45 37 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1/T1</italic>
###xml 53 56 53 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GST</italic>
Polymerase chain reaction results of GSTM1/T1 genes. GST, glutathione S-transferase.
###end p 74
###begin p 75
Demographic characteristics of subjects
###end p 75
###begin p 76
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 34 40 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
###xml 40 41 35 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 60 73 55 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8225;</sup>
###xml 73 74 56 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
*p<0.001 vs. group B and group C; daggerp<0.05 vs. group C; double daggerp<0.05 vs. group B and group C.
###end p 76
###begin p 77
Group A, >/=50% in luminal diameter stenosis in coronary angiography; Group B, 20-50% in luminal diameter stenosis in coronary angiography; Group C, <20% in luminal diameter stenosis in coronary angiography. BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.
###end p 77
###begin p 78
###xml 14 22 14 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1/T1</italic>
###xml 46 47 46 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
Comparison of GSTM1/T1 genotype among 3 groups*
###end p 78
###begin p 79
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 18 29 18 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1/GSTT1</italic>
*Valid results of GSTM1/GSTT1 genotype were 692 of 775 subjects (89.3%).
###end p 79
###begin p 80
Group A, >/=50% in luminal diameter stenosis in coronary angiography; Group B, 20-50% in luminal diameter stenosis in coronary angiography; Group C, <20% in luminal diameter stenosis in coronary angiography. GST, glutathione S-transferase.
###end p 80
###begin p 81
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
Interaction between GSTM1 genotype and smoking on CAD
###end p 81
###begin p 82
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
*reference.
###end p 82
###begin p 83
Group A, >/=50% in luminal diameter stenosis in coronary angiography; Group B, 20-50% in luminal diameter stenosis in coronary angiography; Group C, <20% in luminal diameter stenosis in coronary angiography.
###end p 83
###begin p 84
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GST</italic>
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 117 122 117 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
GST, glutathione S-transferase; CAD, coronary artery disease; OR, odds ratio; M1(+), GSTM1-positive genotype; M1(-), GSTM1 null genotype; NS, non-smoker; S, smoker.
###end p 84
###begin p 85
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
Interaction between GSTT1 genotype and smoking on CAD
###end p 85
###begin p 86
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
*, reference.
###end p 86
###begin p 87
Group A, >/=50% in luminal diameter stenosis in coronary angiography; Group B, 20-50% in luminal diameter stenosis in coronary angiography; Group C, <20% in luminal diameter stenosis in coronary angiography.
###end p 87
###begin p 88
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GST</italic>
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 117 122 117 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
GST, glutathione S-transferase; CAD, coronary artery disease; OR, odds ratio; T1(+), GSTT1-positive genotype; T1(-), GSTT1 null genotype; NS, non-smoker; S, smoker.
###end p 88
###begin p 89
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
Interaction between GSTM1 genotype and smoking on CAD after adjusting for other risk factors
###end p 89
###begin p 90
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 14 20 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
*, reference; dagger, adjusted for age, sex, hypertension, DM, body mass index, and lipid profile.
###end p 90
###begin p 91
Group A, >/=50% in luminal diameter stenosis in coronary angiography; Group B, 20-50% in luminal diameter stenosis in coronary angiography; Group C, <20% in luminal diameter stenosis in coronary angiography.
###end p 91
###begin p 92
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GST</italic>
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 117 122 117 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
GST, glutathione S-transferase; CAD, coronary artery disease; OR, odds ratio; M1(+), GSTM1-positive genotype; M1(-), GSTM1 null genotype; NS, non-smoker; S, smoker.
###end p 92
###begin p 93
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
Interaction between GSTT1 genotype and smoking on CAD after adjusting for other risk factors
###end p 93
###begin p 94
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 12 18 12 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
*reference; dagger, adjusted for age, sex, hypertension, DM, body mass index, and lipid profile.
###end p 94
###begin p 95
Group A, >/=50% in luminal diameter stenosis in coronary angiography; Group B, 20-50% in luminal diameter stenosis in coronary angiography; Group C, <20% in luminal diameter stenosis in coronary angiography.
###end p 95
###begin p 96
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GST</italic>
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 117 122 117 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
GST, glutathione S-transferase; CAD, coronary artery disease; OR, odds ratio; T1(+), GSTT1-positive genotype; T1(-), GSTT1 null genotype; NS, non-smoker; S, smoker.
###end p 96
###begin p 97
###xml 26 29 26 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GST</italic>
Genotype distributions of GST gene according to the number of affected vessels
###end p 97
###begin p 98
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GST</italic>
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 68 73 68 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 93 98 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 102 107 102 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 123 128 123 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 132 137 132 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 157 162 157 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 166 171 166 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 195 203 195 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1/T1</italic>
###xml 236 244 236 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1/T1</italic>
GST, glutathione S-transferase; NS, non-smoker; S, smoker; GSTM1-1, GSTM1-positive genotype; GSTM1-0, GSTM1 null genotype; GSTT1-1, GSTT1-positive genotype; GSTT1-0, GSTT1 null genotype; both-1, GSTM1/T1 both positive genotype; both-0, GSTM1/T1 both null genotype.
###end p 98
###begin p 99
###xml 26 29 26 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GST</italic>
Genotype distributions of GST gene according to the severity of CAD
###end p 99
###begin p 100
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GST</italic>
###xml 222 229 222 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1-1</italic>
###xml 231 236 231 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 256 261 256 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 265 270 265 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 286 291 286 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 295 300 295 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 320 325 320 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 329 334 329 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
###xml 358 366 358 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1/T1</italic>
###xml 399 407 399 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1/T1</italic>
GST, glutathione S-transferase; CAD, coronary artery disease; mild, 50-75% of luminal diameter stenosis; moderate, 76-90% of luminal diameter stenosis; severe, >90% of luminal diameter stenosis; NS, non-smoker; S, smoker; GSTM1-1, GSTM1-positive genotype; GSTM1-0, GSTM1 null genotype; GSTT1-1, GSTT1-positive genotype; GSTT1-0, GSTT1 null genotype; both-1, GSTM1/T1 both positive genotype; both-0, GSTM1/T1 both null genotype.
###end p 100
###begin p 101
Independent risk factors of CAD
###end p 101
###begin p 102
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
*age >/=50 yr.
###end p 102
###begin p 103
###xml 46 49 46 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GST</italic>
###xml 78 85 78 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1/S</italic>
###xml 87 92 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTM1</italic>
###xml 118 125 118 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1/S</italic>
###xml 127 132 127 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTT1</italic>
CAD, coronary artery disease; OR, odds ratio; GST, glutathione S-transferase; GSTM1/S, GSTM1 null genotype in smoker; GSTT1/S, GSTT1 null genotype in smoker.
###end p 103

